Showing results (461-470 of 925) with videos related to
Sort By:
Pageof 93
Immunobiology|July 31, 2018
MRP8/14 does not contribute to dissemination or inflammation in a murine model of Lyme borreliosisLauren M K Mason, Jeroen Coumou, Jasmin I Ersöz, et al.RMD Open|May 18, 2021
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident RegistryUlrich A Walker, Hugh H Tilson, Philip N Hawkins, et al.The Lancet. Respiratory Medicine|November 28, 2021
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumoniaJean-Louis Vincent, Marcel Levi, Beverley J HuntJournal of the American Society of Nephrology : JASN|April 3, 2010
Uremic thrombocytopathy is not about ureaGabor E Linthorst, Hans J Avis, Marcel LeviThrombosis and Haemostasis|April 26, 2013
Evolution of Factor V LeidenThijs E van Mens, Marcel Levi, Saskia MiddeldorpCurrent Opinion in Critical Care|January 17, 2017
Microbiota-targeted therapies on the intensive care unitBastiaan W Haak, Marcel Levi, W Joost WiersingaSeminars in Hematology|February 12, 2004
Recombinant factor VIIa as an antidote for anticoagulant treatmentMarcel Levi, N R Bijsterveld, T T KellerAntimicrobial Agents and Chemotherapy|August 16, 2022
The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureusAnno Saris, Wanhai Qin, Christine C A van Linge, et al.Plos One|May 21, 2015
Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae PneumoniaFlorry E van den Boogaard, Jorrit J Hofstra, Cornelis van 't Veer, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|February 23, 2016
An Ixodes ricinus Tick Salivary Lectin Pathway Inhibitor Protects Borrelia burgdorferi sensu lato from Human ComplementAlex Wagemakers, Jeroen Coumou, Tim J Schuijt, et al.Pageof 93